Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi

African Journal of Laboratory Medicine

 
 
Field Value
 
Title Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi
 
Creator Chikaonda, Tarsizio Ketseoglou, Irene Nguluwe, Nelson Krysiak, Robert Thengolose, Isaac Nyakwawa, Felix Rosenberg, Nora E. Stanley, Christopher Mpunga, James Hoffman, Irving F. Papathanasopoulos, Maria A. Hosseinipour, Mina Scott, Lesley Stevens, Wendy
 
Subject Health Sciences Rifampicin resistance; Xpert; DNA sequencing; rpoB mutation.
Description Background: Availability and access to the detection of resistance to anti-tuberculosis drug sremains a significant challenge in Malawi due to limited diagnostic services. The Xpert® MTB/RIF can detect Mycobacterium tuberculosis and resistance to rifampicin in a single, rapid assay. Rifampicin-resistant M. tuberculosis has not been well studied in Malawi.Objectives: We aimed to determine mutations in the rifampicin resistance determining region (RRDR) of the rpoB gene of M. tuberculosis strains which were defined as resistant to rifampicin by the Xpert MTB/RIF assay.Methods: Rifampicin-resistant isolates from 43 adult patients (≥ 18 years) from various districts of Malawi were characterised for mutations in the RRDR (codons 507–533) of the rpoB gene by DNA sequencing.Results: Mutations were found in 37/43 (86%) of the resistant isolates in codons 511, 512, 513,516, 522, 526 and 531. The most common mutations were in codons 526 (38%), 531 (29.7%) and 516 (16.2%). Mutations were not found in 6/43 (14%) of the resistant isolates. No novel rpoB mutations other than those previously described were found among the rifampicin-resistant M. tuberculosis complex strains.Conclusion: This study is the first to characterise rifampicin resistance in Malawi. The chaintermination DNA sequencing employed in this study is a standard method for the determination of nucleotide sequences and can be used to confirm rifampicin resistance obtained using other assays, including the Xpert MTB/RIF. Further molecular cluster analysis, such as spoligotyping and DNA finger printing, is still required to determine transmission dynamics and the epidemiological link of the mutated strains.
 
Publisher AOSIS
 
Contributor
Date 2017-03-31
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/ajlm.v6i2.463
 
Source African Journal of Laboratory Medicine; Vol 6, No 2 (2017); 7 pages 2225-2010 2225-2002
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://ajlmonline.org/index.php/ajlm/article/view/463/797 https://ajlmonline.org/index.php/ajlm/article/view/463/796 https://ajlmonline.org/index.php/ajlm/article/view/463/798 https://ajlmonline.org/index.php/ajlm/article/view/463/782
 
Coverage — — —
Rights Copyright (c) 2017 Tarsizio Chikaonda, Irene Ketseoglou, Nelson Nguluwe, Robert Krysiak, Isaac Thengolose, Felix Nyakwawa, Nora E. Rosenberg, Christopher Stanley, James Mpunga, Irving F. Hoffman, Maria A. Papathanasopoulos, Mina Hosseinipour, Lesley Scott, Wendy Stevens https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT